The ballon sinus dilation segment dominates the market, but sinus stents are catching up fast.
The growing popularity of surgical procedures to treat sinusitis has boosted the sinus dilation market in Asia Pacific, which is expected to reach $743m in 2027 from $354m in 2019, according to ReportLinker.
Incidences of chronic rhinosinusitis (CRS) have been rising continuously, affecting one in seven people across the world. Subsequently, this has driven the implementation of long-term medical management and functional endoscopic sinus surgery (FESS), the report noted.
However, the high cost of sinus dilation procedure is about to hinder the growth of the market during the period.
Still, technological developments allow various market players to innovate technically advanced medical devices to efficiently treat CRS through minimally invasive procedures. For instance, various market leaders have been developing balloon sinus dilation devices.
"Growing awareness about the developments in medical technology has increased the adoption of minimally invasive procedures.Balloon sinuplasty is an emerging technology in developed regions and penetrates in developing as well as developed regions," the report stated.
In 2019, the balloon sinus dilation segment dominated the market, beating endoscopes, sinus stents, and handheld instruments by market share. However, the sinus stent segment is tipped to grow at the fastest rate in the coming years.
By procedures, the standalone sinus dilation procedure segment held the largest share of the market, but the hybrid sinus dilation procedure segment is anticipated to grow at the fastest rate over the same period.
Do you know more about this story? Contact us anonymously through this link.